{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T09:18:46Z","timestamp":1782379126648,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jmii.2011.12.019","type":"journal-article","created":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T17:46:37Z","timestamp":1336153597000},"page":"424-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli"],"prefix":"10.1016","volume":"49","author":[{"given":"Hui-Hsiu","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuarn-Jang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2011.12.019_bib1","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.amjmed.2008.04.039","article-title":"Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates","volume":"121","author":"Johnson","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.jmii.2011.12.019_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jmii.2011.01.015","article-title":"Consensus statement on the role of fluoroquinolones in the management of urinary tract infections","volume":"44","author":"Hsueh","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.12.019_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1684-1182(10)60038-2","article-title":"Clinical implications, risk factors and mortality following community-onset bacteremia caused by extended-spectrum \u03b2-lactamase (ESBL) and non-ESBL producing Escherichia coli","volume":"43","author":"Hsieh","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.12.019_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1684-1182(10)60055-2","article-title":"A continuous challenge from Gram-negative bacteria: more carbapenemases","volume":"43","author":"Chen","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2011.12.019_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib6","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dkq351","article-title":"Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital","volume":"65","author":"Gallini","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib7","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.48.6.1934-1940.2004","article-title":"The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported","volume":"48","author":"Bolon","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/379709","article-title":"Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000","volume":"37","author":"Zervos","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib9","series-title":"Performance standards for antimicrobial susceptibility testing; 20th informational supplement (June 2010 update)","author":"Clinical and Laboratory Standard Institute","year":"2010"},{"key":"10.1016\/j.jmii.2011.12.019_bib10","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1128\/AAC.43.11.2736","article-title":"Emergence and dissemination of quinolone-resistant Escherichia coli in the community","volume":"43","author":"Garau","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib11","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3201\/eid0805.010204","article-title":"Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999","volume":"8","author":"Livermore","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7883\/yoken.JJID.2008.226","article-title":"Significance of fluoroquinolone-resistant Escherichia coli in urinary tract infections","volume":"61","author":"Shigemura","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijantimicag.2009.11.007","article-title":"Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use","volume":"35","author":"Lee","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2011.12.019_bib14","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajem.2010.09.030","article-title":"High rates of quinolone resistance among urinary tract infections in the ED","volume":"30","author":"Khawcharoenporn","year":"2012","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jmii.2011.12.019_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1073\/pnas.96.3.1152","article-title":"The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance","volume":"96","author":"Austin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jmii.2011.12.019_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/jac\/dki136","article-title":"Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli","volume":"55","author":"Marcusson","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib19","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jac\/dkn229","article-title":"A unified anti-mutant dosing strategy","volume":"62","author":"Zhao","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jac\/dkh036","article-title":"Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin, or trovafloxacin for Escherichia coli under different growth conditions","volume":"53","author":"Linde","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2011.12.019_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1086\/432056","article-title":"Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals","volume":"41","author":"MacDougall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1086\/374221","article-title":"Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital","volume":"36","author":"Muller","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2011.12.019_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/aje\/kwf173","article-title":"Risk factors for resistance to antimicrobial agents among nursing home residents","volume":"157","author":"Loeb","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jmii.2011.12.019_bib24","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1086\/523280","article-title":"Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals","volume":"28","author":"Rogues","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2011.12.019_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jmii.2011.03.001","article-title":"Emergence and spread of multi-drug resistant organisms: think globally and act locally","volume":"44","author":"Tseng","year":"2011","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211002568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118211002568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:20:44Z","timestamp":1761657644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118211002568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1684118211002568"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2011.12.019","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between levofloxacin consumption and the incidence of nosocomial infections due to fluoroquinolone-resistant Escherichia coli","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2011.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}